TRAIL Score:A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma
Will Harris, Carsten Henneges(Eli Lilly (Germany)), Vaikunth Cuchelkar, Edward Bataillard(National Health Service), Daniel Schneider(William James College), Antonia Kwan, Joseph N. Paulson(Applied Mathematics (United States)), Yoonha Choi(Ewha Womans University), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Tina Nielsen(Roche (Switzerland))
VBN Forskningsportal (Aalborg Universitet)
January 1, 2022
Cited by 2
Related Papers
Multivariable association discovery in population-scale meta-omics studies
|PLoS Computational Biology|2021|2.5k
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
|The Lancet Oncology|2019|564
Multivariable Association Discovery in Population-scale Meta-omics Studies
|bioRxiv (Cold Spring Harbor Laboratory)|2021|471
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
|The Lancet Oncology|2022|429
Variation and genetic control of protein abundance in humans
|Nature|2013|403